Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Biopharma Laboratory Services (BLS). The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs), including health fairs, on-site and at-home testing, vaccinations, and health screenings. In addition, the company offers online and mobile applications that enable patients to check test results; online applications for providers, MCOs, and accountable care organizations; and drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent c
The current price of LH.BOATS is $272.35 USD — it has increased by +0% in the past 24 hours. Watch Labcorp stock price performance more closely on the chart.
What is Labcorp stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Labcorp stocks are traded under the ticker LH.BOATS.
What is Labcorp market cap?▼
Today Labcorp has the market capitalization of 22.58B
When is the next Labcorp earnings date?▼
Labcorp is going to release the next earnings report on February 17, 2026.
What were Labcorp earnings last quarter?▼
LH.BOATS earnings for the last quarter are 4.18 USD per share, whereas the estimation was 4.13 USD resulting in a +1.21% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Labcorp revenue for the last year?▼
Labcorp revenue for the last year amounts to 26.02B USD.
What is Labcorp net income for the last year?▼
LH.BOATS net income for the last year is 1.49B USD.
Does Labcorp pay dividends?▼
Yes, LH.BOATS dividends are paid quarterly. The last dividend per share was 0.72 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Labcorp have?▼
As of February 02, 2026, the company has 67,000 employees.